We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+3.56%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$4.99B
AUM Growth
-$200M
Cap. Flow
-$628M
Cap. Flow %
-12.59%
Top 10 Hldgs %
53.63%
Holding
424
New
126
Increased
60
Reduced
38
Closed
165
Avg Time Held Equity + Options
1.8 quarters
Top 10 Avg Time Held Equity + Options
1.4 quarters
Top 20 Avg Time Held Equity + Options
1.3 quarters
Avg Time Held Equity only
1.9 quarters
Top 10 Avg Time Held Equity only
1.4 quarters
Top 20 Avg Time Held Equity only
1.3 quarters

Sector Composition

Rank Sector Weight
1 Financials 21.62%
2 Technology 20.95%
3 Industrials 12.75%
4 Miscellaneous 12.61%
5 Communication Services 6.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
INFN icon
351
DELISTED
Infinera Corporation Common Stock
INFN
– –
-22,874
Closed -$248K –
CDMO icon
352
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
– –
-150,900
Closed -$441K –
NVTA
353
DELISTED
Invitae Corporation
NVTA
– –
-529,466
Closed -$2.48M –
ATTO
354
DELISTED
Atento S.A.
ATTO
– –
-18,540
Closed -$727K –
DRE
355
DELISTED
Duke Realty Corp.
DRE
– –
-143,300
Closed -$3.79M –
TYME
356
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
– –
-71,233
Closed -$159K –
ZNGA
357
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
– –
-725,808
Closed -$2.66M –
MIME
358
DELISTED
Mimecast Limited
MIME
– –
-93,029
Closed -$3.3M –
ARNA
359
DELISTED
Arena Pharmaceuticals Inc
ARNA
– –
-56,576
Closed -$2.23M –
NUAN
360
DELISTED
Nuance Communications, Inc.
NUAN
– –
-105,151
Closed -$1.43M –
GDP
361
DELISTED
Goodrich Petroleum Corporation Common Stock
GDP
– –
-15,000
Closed -$165K –
NAV
362
DELISTED
Navistar International
NAV
– –
-14,638
Closed -$512K –
STAY
363
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
– –
-91,737
Closed -$1.81M –
SYNC
364
DELISTED
Synacor, Inc.
SYNC
– –
-36,908
Closed -$59K –
GPOR icon
365
DELISTED
Gulfport Energy Corp.
GPOR
– –
-500,000
Closed -$4.83M –
IBKC
366
DELISTED
IBERIABANK Corp
IBKC
– –
-120,000
Closed -$9.36M –
ARCH icon
367
DELISTED
Arch Resources, Inc.
ARCH
– –
-20,853
Closed -$1.92M –
ZAYO
368
DELISTED
Zayo Group Holdings, Inc.
ZAYO
– –
-76,822
Closed -$2.62M –
BOLD icon
369
DELISTED
Audentes Therapeutics, Inc
BOLD
– –
-55,085
Closed -$1.66M –
VIAB
370
DELISTED
Viacom Inc. Class B
VIAB
– –
-45,576
Closed -$1.42M –
AABA
371
DELISTED
Altaba Inc
AABA
– –
-19,275
Closed -$1.43M –
ONCS
372
DELISTED
OncoSec Medical Incorporated
ONCS
– –
-1,225
Closed -$507K –
CMTA
373
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
– –
-43,866
Closed -$665K –
TFCFA
374
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
– –
-402,078
Closed -$15.9M –
HYACU icon
375
DELISTED
Haymaker Acquisition Corp. Unit
HYACU
– –
-209,154
Closed -$2.08M –

Similar funds

UBS O'Connor's Q2 2018 Portfolio in Review

As of Q2 2018, UBS O'Connor held 424 positions worth $4.99B, down 3.9% from $5.19B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

UBS O'Connor withdrew a net $628M in Q2 2018, closing 165 positions and reducing 38 holdings. Its most notable exit was Monsanto Co, an estimated $526M position sold in full.

By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 20% a quarter earlier, followed by Technology and Industrials.

Against the trend, UBS O'Connor opened a new position in Envision Healthcare Holdings Inc worth $94.6M.

  • UBS O'Connor's largest Q2 2018 buy was Envision Healthcare Holdings Inc: 2,150,000 shares worth $94.6M.
  • UBS O'Connor added most to Andeavor in Q2 2018, an estimated $273M increase.
  • UBS O'Connor's biggest Q2 2018 reduction was Aetna Inc, cutting an estimated $126M.
  • UBS O'Connor fully exited Monsanto Co in Q2 2018, selling an estimated $526M.
  • UBS O'Connor's ten largest holdings make up 54% of its $4.99B portfolio in Q2 2018.
  • UBS O'Connor opened 126 new positions and closed 165 in Q2 2018.
  • UBS O'Connor's portfolio value fell 3.9% quarter-over-quarter to $4.99B.

Based on UBS O'Connor's 13F filing for Q2 2018, filed 14 Aug 2018.